Mendelian randomisation and experimental medicine approaches to IL-6 as a drug target in PAH

MLA

Toshner, Mark, et al. Mendelian Randomisation and Experimental Medicine Approaches to IL-6 as a Drug Target in PAH. Feb. 2022. EBSCOhost, https://doi.org/10.17863/cam.81811.

APA

Toshner, M., Church, C., Harbaum, L., Rhodes, C., Villar Moreschi, S. S., Liley, J., Jones, R., Arora, A., Batai, K., Desai, A. A., Coghlan, J. G., Gibbs, J. S. R., Gor, D., Gräf, S., Harlow, L., Hernandez-Sanchez, J., Howard, L. S., Humbert, M., Karnes, J., … Corris, P. A. (2022). Mendelian randomisation and experimental medicine approaches to IL-6 as a drug target in PAH. https://doi.org/10.17863/cam.81811

Chicago

Toshner, Mark, Colin Church, Lars Harbaum, Christopher Rhodes, Sofia S Villar Moreschi, James Liley, Rowena Jones, et al. 2022. “Mendelian Randomisation and Experimental Medicine Approaches to IL-6 as a Drug Target in PAH,” February. doi:10.17863/cam.81811.